InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,214.08
(
0.51%
)
US TECH 100
17,720.40
(
0.45%
)
Dow Jones
39,387.76
(
0.85%
)
Brent Oil
84.14
(
0.22%
)
Bitcoin
62,954.30
(
-0.15%
)
Post# of 13897
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Iam_in

Send PM Follow Ignore
Followers 2
Posts 266
Boards Moderated 0
Alias Born 08/12/2016

Iam_in

Re: None

Thursday, 07/13/2017 3:11:09 AM

Thursday, July 13, 2017 3:11:09 AM

Post# of 13897
NEW PR : IMMUNE Pharmaceuticals' Oncology subsidiary, CYTOVIA, announces the filing of a world-wide patent protecting the use of Ceplene® in acute myeloid leukemia (AML) and other hematological cancers with mutated NPM1 (beQuoted)
2017-07-13 08:27 ( swedish time )

full text:

https://www.avanza.se/placera/pressmeddelanden/2017/07/13/immune-pharmaceuticals-immune-pharmaceuticals-immune-pharmaceuticals-oncology-subsidiary-cytovia-announces-the-filing-of-a-world-wide-patent-protecting-the-use-of-ceplene-in-acute-myeloid-leukemia-aml-and-other-hematological-cancers-with-mutatednpm1.html


Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up